NASONEX
LOE ApproachingNDANASALSPRAY, METERED
Approved
Oct 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
2/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NASONEX is a metered nasal spray approved in 1997 for seasonal allergic rhinitis. The product is a small-molecule corticosteroid administered intranasally to reduce allergic inflammation. It represents a mature, well-established treatment option in the allergic rhinitis market.
LOE Approaching
Product is entering late-stage lifecycle with approaching loss of exclusivity, signaling potential contraction in team size and budget allocation toward pipeline assets.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
Started Jul 2009
540 enrolled
Rhinitis, Allergic, Perennial
Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)
Started Apr 2003
188 enrolled
Rhinitis, Allergic, SeasonalAsthma
Career Relevance
Working on NASONEX offers stable, mature-market experience in a well-understood therapeutic category with established customer relationships and reimbursement infrastructure. However, the approaching LOE and zero linked job openings signal limited growth opportunity; roles are likely contracting as the company redirects resources to newer pipeline assets.
Worked on NASONEX at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.